Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy

Circulation

Volumn 124, Issue 1, 2011, Pages 40-47

  Maron, Martin S ^a   Olivotto, Iacopo ^b   Harrigan, Caitlin ^a   Appelbaum, Evan ^c   Gibson, C Michael ^c   Lesser, John R ^d   Haas, Tammy S ^d   Udelson, James E ^a   Manning, Warren J ^c   Maron, Barry J ^d  

^a TUFTS MEDICAL CENTER   (United States)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

cardiomyopathy, hypertrophic; magnetic resonance imaging; mitral valve

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MITRAL VALVE DISEASE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MITRAL VALVE; PHENOTYPE; VENTRICULAR OUTFLOW OBSTRUCTION; YOUNG ADULT;

EID: 79960381831     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.985812     Document Type: Article

References (47)

1. Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG. Idio-pathic Hypertrophic subaortic stenosis, I: a description of the disease based upon an analysis of 64 patients. Circulation. 1964;30:(suppl IV): IV-3-IV-119.
2. Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol. 2008;19:104-110.
3. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308-1320 (Pubitemid 34250486)
4. Maron BJ, McKenna WJ, Danielson GK, Kappenberger CJ, Kahn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42: 1687-1713. (Pubitemid 37383745)
5. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic car-diomyopathy: clinical spectrum and treatment. Circulation. 1995;92: 1680-1692.
6. Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation. 1992;85:1651-1660.
7. Klues HG, Proschan MA, Dollar AL, Spirito P, Roberts WC, Maron BJ. Echocardiographic assessment of mitral valve size in obstructive hyper-trophic cardiomyopathy: anatomic validation from mitral valve specimen. Circulation. 1993;88:548-555. (Pubitemid 23228054)
8. Lima JA, Desai MY. Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol. 2004;44: 1164-1171. (Pubitemid 39208868)
9. Pennell DJ. Cardiovascular magnetic resonance. Circulation. 2010;121: 692-705.
10. Han Y, Peters DC, Salton CJ, Byzmek D, Nezafat R, Goddu B, Kissinger KV, Zimetbaum PJ, Manning WJ, Yeon SB. Cardiovascular magnetic resonance characterization of mitral valve prolapse. J Am Coll Cardiol Cardiovasc Imaging. 2008;1:294-303. (Pubitemid 351676841)
11. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003; 348:295-303. (Pubitemid 36119984)
12. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232-2239. (Pubitemid 44789498)
13. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114: 216-225. (Pubitemid 44297115)
14. Petrone RK, Klues HG, Panza JA, Peterson EE, Maron BJ. Coexistence of mitral valve prolapse in a consecutive group of 528 patients with hypertrophic cardiomyopathy assessed with echocardiography. J Am Coll Cardiol. 1992;20:55-61.
15. Klues HG, Roberts WC, Maron BJ. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomy-opathy: significance in producing left ventricular outflow obstruction. Circulation. 1991;84:1188-1197.
16. Harrigan CJ, Maron MS, Maron BJ, Peters DC, Gibson CM, Manning WJ, Appelbaum E. Accuracy and reproducibility of quantifying myo-cardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance techniques. Radiology. 2011;258:128-133.
17. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104: 557-567. (Pubitemid 32201950)
18. Olivotto I, Girolami F, Ackerman MJ, Nistri S, Bos JM, Zachara E, Ommen SR, Theis JL, Vaubel RA, Re F, Armentano C, Poggesi C, Torricelli F, Cecchi F. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc. 2008;83:630-638. (Pubitemid 351810562)
19. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic car-diomyopathy. N Engl J Med. 2003;349:1027-1035. (Pubitemid 37087617)
20. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54:220-228.
21. Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hyper-trophic cardiomyopathy. Circulation. 2008;118:1541-1549.
22. Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, Torricelli F, Camici PG. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hyper-trophic cardiomyopathy. J Am Coll Cardiol. 2006;47:1043-1048.
23. Perkins MJ, Van Driest SL, Ellsworth EG, Will ML, Gersh BJ, Ommen SR, Ackerman MJ. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur Heart J. 2005;26:2457-2462. (Pubitemid 41552976)
24. van der Merwe L, Cloete R, Revera M, Heradian M, Goosen A, Corfield VA, Brink PA, Moolman-Smook JC. Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy. Hum Genet. 2008;124: 57-61.
25. Klues HG, Roberts WC, Maron BJ. Morphological determinants of echo-cardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy. Circulation. 1993;87: 1570-1579. (Pubitemid 23133102)
26. Levine RA, Vlahakes GJ, Lefebvre X, Guerrero JL, Cape EG, Yoga-nathan AP, Weyman AE. Papillary muscle displacement causes systolic anterior motion of the mitral valve: experimental validation and insights into the mechanism of subaortic obstruction. Circulation. 1995;91: 1189-1195.
27. Sherrid MV, Chaudhry FA, Swistel DG. Obstructive hypertrophic car-diomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg. 2003;75: 620-632. (Pubitemid 36184532)
28. Sherrid MV, Chu CK, Delia E, Mogtader A, Dwyer EM Jr. An echocar-diographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993;22:816-825. (Pubitemid 23256945)
29. He S, Hopmeyer J, Lefebvre XP, Schwammenthal E, Yoganathan AP, Levine RA. Importance of leaflet elongation in causing systolic anterior motion of the mitral valve. J Heart Valve Dis. 1997;6:149-159. (Pubitemid 27166176)
30. Jiang L, Levine RA, King ME, Weyman AE. An integrated mechanism for systolic anterior motion of the mitral valve in hypertrophic cardio-myopathy based on echocardiographic observations. Am Heart J. 1987; 113:633-644. (Pubitemid 17036711)
31. Balaram SK, Sherrid MV, Derose JJ Jr, Hillel Z, Winson G, Swistel DG. Beyond extended myectomy for hypertrophic cardiomyopathy: the resection-plication-release (RPR) repair. Ann Thorac Surg. 2005;80: 217-223. (Pubitemid 40840212)
32. Balaram SK, Tyrie L, Sherrid MV, Afthinos J, Hillel Z, Winson G, Swistel DG. Resection-plication-release for hypertrophic cardiomyopa-thy: clinical and echocardiographic follow-up. Ann Thorac Surg. 2008; 86:1539-1544.
33. Kofflard MJ, van Herwerden LA, Waldstein DJ, Ruygrok P, Boersma E, Taams MA, Ten Cate FJ. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic car-diomyopathy. J Am Coll Cardiol. 1996;28:197-202.
34. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ, Nishimura RA. The case for surgery in obstructive hypertrophic cardio-myopathy. J Am Coll Cardiol. 2004;44:2044-2053. (Pubitemid 39480744)
35. Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg. 2004;127:481-489. (Pubitemid 38180530)
36. Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation. 1995;92:II122-127.
37. van der Lee C, Kofflard MJ, van Herwerden LA, Vletter WB, ten Cate FJ. Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy. Circulation. 2003;108:2088-2092. (Pubitemid 37337584)
38. Schwammenthal E, Levine RA. Dynamic subaortic obstruction: a disease of the mitral valve suitable for surgical repair? J Am Coll Cardiol. 1996;28:203-206.
39. McIntosh CL, Maron BJ. Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation. 1988;78:487-495.
40. Yacoub MH. Surgical versus alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the pendulum swings. Circulation. 2005; 112:450-452. (Pubitemid 41060781)
41. McIntosh CL, Maron BJ, Cannon RO 3rd, Klues HG. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Circulation. 1992;86:II-60-67.
42. Grigg LE, Wigle ED, Williams WG, Daniel LB, Rakowski H. Trans-esophageal Doppler echocardiography in obstructive hypertrophic cardio-myopathy: clarification of pathophysiology and importance in intraop-erative decision making. J Am Coll Cardiol. 1992;20:42-52.
43. Ommen SR, Park SH, Click RL, Freeman WK, Schaff HV, Tajik AJ. Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy. Am J Cardiol. 2002;90: 1022-1024. (Pubitemid 35232635)
44. Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, Seidman CE. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol. 2001;38:315-321. (Pubitemid 32721755)
45. Ho CY, Seidman CE. A contemporary approach to hypertrophic cardio-myopathy. Circulation. 2006;113:e858-e862.
46. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855-861. (Pubitemid 41170072)
47. Maron MS, Lesser JR, Maron BJ. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance. Am J Cardiol. 2010;105:1842-1843.